So I think that hopefully with people like me in Congress asking the questions of the administration, when that FDA director is being vetted and chosen and all that we can head in the right direction. And we've seen, I mean, we've, We've seen at the FDA level things kind of go more your way a few years ago, very temporarily, for a few months. as I recall. But I think we've got an opportunity, depending on who's in the White House. After Brian leaves and goes to Philip Morris. Yeah. (1:04:05–1:04:16)
CLAIM
Asserts that there was a temporary period when FDA policies aligned more with certain interests.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
